Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/10442/19371
Εξειδίκευση τύπου : | Άρθρο σε επιστημονικό περιοδικό |
Τίτλος: | ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review) |
Δημιουργός/Συγγραφέας: | Varisli, Lokman Zoumpourlis, Panagiotis Spandidos, Demetrios A [EL] Ζουμπουρλής, Βασίλης[EN] Zoumpourlis, Vassilis Vlahopoulos, Spiros |
Ημερομηνία: | 2025-05 |
Γλώσσα: | Αγγλικά |
ISSN: | 1792-1074 1792-1082 |
DOI: | 10.3892/ol.2025.14959 |
Άλλο: | 40093866 |
Περίληψη: | The expression of cytosolic aldehyde dehydrogenases (ALDHs), which mediate the last step in the pathway of the synthesis of all-trans retinoic acid, is dysregulated in various types of human cancer, and has been associated with the development of cancer stem cells (CSCs) in solid tumors and hematological malignancies. CSCs are considered a minor fraction of cancer cells with the capacity to initiate neoplastic tumors. ALDH1A1 serves a crucial role in the emergence of the CSC phenotype, induces the malignant behavior of cancer cells and promotes treatment resistance. Notably, ALDH1A1-induced therapy resistance is not exclusive to just one group of drugs, but affects diverse types of drugs that use different mechanisms to kill cells. This diversity of drug resistance-inducing effects is associated with the stemness-supporting functions of ALDH1A1. The inhibition of ALDH1A1 activity using chemicals or the depletion of ALDH1A1 via genetic approaches, such as the use of small interfering RNA, can overcome diverse pathways of therapy resistance. In the context of breast cancer, it is critical that only a fraction of malignant cells are expected to manifest stem-like features, which include increased expression of ALDH1A1. From the angle of disease prognosis, the extent of the association of ALDH1A1 with increased malignant behavior and drug resistance remains to be determined through the application of cutting-edge methods that detect the expression of tracked biomarkers within tumors. |
Τίτλος πηγής δημοσίευσης: | Oncology letters |
Τόμος/Κεφάλαιο: | 29 |
Τεύχος: | 5 |
Θεματική Κατηγορία: | [EL] Μοριακή Βιολογία[EN] Molecular Biology [EL] Νεοπλάσματα. Όγκοι. Ογκολογία (περ. Καρκίνος, κακινογόνες ουσίες)[EN] Neoplasms. Tumors. Oncology (Incl.cancer, carcinogens) [EL] Βιοχημεία[EN] Biochemistry |
Λέξεις-Κλειδιά: | aldehyde dehydrogenase cancer progression cancer stem cells drug resistance quiescence retinoic acid |
Κάτοχος πνευματικών δικαιωμάτων: | © Varisli et al |
Όροι και προϋποθέσεις δικαιωμάτων: | This is an open access article distributed under the terms of Creative Commons Attribution License. |
Ηλεκτρονική διεύθυνση στον εκδότη (link): | https://doi.org/10.3892/ol.2025.14959 |
Εμφανίζεται στις συλλογές: | Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο
|